Firstly, circCDYL promoted progression of BC mainly via miR-1275-ATG7/ULK1-autophagy axic in HER2– BC (Liang et al., 2020), while circCDYL promoted progression of HER2+ BC via activation of PI3K-AKT pathway. Here, ERBB2 is linked to breast cancer.